Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2010
09/14/2010US7795221 with N-terminus and C-terminus which bind to natriuretic peptide receptor and include plurality of amino acid residues and amino acid surrogate; for treating congestive heart failure, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired
09/14/2010US7795220 biologically active peptide for use in limiting undesired bone loss in a vertebrate at risk of such bone loss, in treating conditions that are characterized by undesired bone loss or by the need for bone growth, e.g. in treating fractures or cartilage disorders and for raising camp levels in cells
09/14/2010US7795219 Use of an agent that restores tissue perfusion and oxygenation
09/14/2010US7795218 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
09/14/2010US7795217 anticarcinogenic biodrugs for treating cancer; inhibitors of cyclin-dependent kinases
09/14/2010US7795216 Methods for promoting composite tissue regeneration and uses thereof
09/14/2010US7795215 MNTF peptides and compositions and methods of use
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010US7795213 Methods of contacting β amyloid protein with VEGF
09/14/2010US7795212 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors
09/14/2010US7795210 Protein remodeling methods and proteins/peptides produced by the methods
09/14/2010US7795209 Anti-angiogenic methods and compositions
09/14/2010US7795208 Using enzyme inhibitors of histone deacetylase to enhance progenitor cell differentiation; regenerative medicine and treatment of nervous system disorders
09/14/2010US7795207 Lipopeptide compositions
09/14/2010US7795206 Peptide that inhibits janus kinase
09/14/2010US7795205 Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
09/14/2010US7795204 supplementing the diet of an athlete with substances which increase the concentration of nitric oxide (NO) or increase its half life in the body, in combination with a source of amino acids, may provide surprising enhancement of an athlete's muscle
09/14/2010US7795202 Inducing the migration of progenitor cells into regions of nervous tissue damage; identify region of nervous tissue damage, incubate with progenitor cells and transforming growth factor, monitor therapeutic response; repair of nervous system injuries or neurodegenerative disorders; tissue repair
09/14/2010US7795032 Methods for proliferating cardiomyocytes and recombinant vectors therefor
09/14/2010US7795016 P185 Neu-encoding DNA and therapeutical uses thereof
09/14/2010US7795002 Which lack fucose and sialic acid residues; recombinant host cells; mannosidases
09/14/2010US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening
09/14/2010US7794987 (R)-2-acetamido-N-benzyl-3-methoxy-propionamide; O-methyl-N-acetyl-D-serine-m-fluorobenzylamide; epilepsy and other CNS disorders
09/14/2010US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
09/14/2010US7794973 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs
09/14/2010US7794965 identifying a compound that modulates methylation of a protein phosphatase that affects a protein activity and determining that the protein activity is altered by modulating with the compound methylation of the protein phosphatase
09/14/2010US7794956 Gab1 involvement in glucose homeostasis regulation by hepatocytes
09/14/2010US7794930 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
09/14/2010US7794929 Detecting a colorectal cancer and/or gastric cancer, detecting selective hybridization of nucleic acid, therapeutic treatment of a cancer, a kit contains oligonucleotide
09/14/2010US7794927 Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
09/14/2010US7794756 Methods of using antibodies to VEGF-C
09/14/2010US7794754 Methods for fine powder formation
09/14/2010US7794742 biomaterial having biocompatible surface comprising immobilized Notch ligand molecules, wherein the plurality of immobilized Notch ligand molecules; transcultaneous biosensor
09/14/2010US7794734 for immunizing cattle against infection from Mannheimia haemolytica; vaccine having purified recombinant PlpE outer membrane protein of Mannheimia with adjuvant; veterinary medicine
09/14/2010US7794733 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof
09/14/2010US7794731 Use of flagellin in the immunotherapy of Yersinia pestis
09/14/2010US7794729 Administering a Listeria vaccine with a strain expressing an antigen fused to a truncated LLO protein; cancer vaccines; anticarcinogenic agents
09/14/2010US7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains
09/14/2010US7794723 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination
09/14/2010US7794709 Flexible, water-impermeable cylindrical covering layer with a proximal sealable open end through which the burned limb is inserted and a distal closed end; the covering layer retains the enzymatic escharotomy agent in close proximity to the burned limb
09/14/2010US7794708 Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening therapeutics of restinosis using said composition
09/14/2010US7794707 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/14/2010CA2546910C Glycopeptide antibiotic derivatives
09/14/2010CA2410965C Method of stimulating hair growth
09/14/2010CA2409406C Qs-21 and il-12 as an adjuvant combination
09/14/2010CA2386231C Membrane translocating peptide drug delivery system
09/14/2010CA2373266C Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/14/2010CA2343569C Mammalian transforming growth factor beta - 9
09/14/2010CA2322792C Polypeptides homologous to vegf and bmp1
09/14/2010CA2320202C Agents and methods for protection, treatment and repair of connective tissue
09/14/2010CA2295140C Stable insulin formulations
09/14/2010CA2277911C Compounds and their combinations for the treatment of influenza infection
09/14/2010CA2262014C Adipogenic differentiation of human mesenchymal stem cells
09/14/2010CA2261666C Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
09/14/2010CA2260291C Antagonists of intestinotrophic glp-2 peptides
09/14/2010CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth
09/14/2010CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
09/10/2010WO2010102281A2 Inhibitors of anaphase promoting complex activity
09/10/2010WO2010102277A2 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
09/10/2010WO2010102266A1 Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects
09/10/2010WO2010102262A1 Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof
09/10/2010WO2010102253A2 Compositions and methods for modulation of cell migration
09/10/2010WO2010102133A1 Artificial oxygen transport protein
09/10/2010WO2010102112A2 Treatment of drug-related side effect and tissue damage by targeting the cd24-hmgb1-siglec10 axis
09/10/2010WO2010102052A2 Methods of inhibiting photoreceptor apoptosis
09/10/2010WO2010102020A1 Insulin formulations for rapid uptake
09/10/2010WO2010101994A2 Gene fusion targeted therapy
09/10/2010WO2010101990A1 Methods of treating lung disease and other inflammatory diseases
09/10/2010WO2010101968A1 Clostridial toxin to improve ejaculate
09/10/2010WO2010101793A2 Methods and compositions for the diagnosis, prognosis and treatment of cancer
09/10/2010WO2010101353A2 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer
09/10/2010WO2010101301A1 Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein
09/10/2010WO2010101257A1 Agent for preventing recurrence of leukemia
09/10/2010WO2010101248A1 Cell proliferation inhibitor and method for screening same
09/10/2010WO2010101237A1 Polypeptides and antibacterial or antiseptic use of same
09/10/2010WO2010101192A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases
09/10/2010WO2010100646A1 Peptides derived from ficolin as surfactants
09/10/2010WO2010100428A2 Compositions and methods
09/10/2010WO2010100385A1 Novel uses of fibrinogen
09/10/2010WO2010100381A1 Novel antiviral agent
09/10/2010WO2010100351A1 Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia
09/10/2010WO2010100310A1 Peptide for the prophylactic or therapeutic treatment of skin tumours in initial stages
09/10/2010WO2010100247A1 Novel therapy for anxiety
09/10/2010WO2010100035A1 Antagonistic peptides for frizzled-1 and frizzled-2
09/10/2010WO2010099955A1 Protease for wound conditioning and skin care
09/10/2010WO2010099746A1 Glucagon-like peptide-2 analogues, preparation method and use thereof
09/10/2010WO2010099703A1 Novel uses of fibrinogen-420 and active domain thereof
09/10/2010WO2010099576A1 Compositions and methods for enhancing immune responses
09/10/2010WO2010099567A1 A method of increasing litter size in mammals
09/10/2010WO2010099556A1 Method for preventing and treating hyperpermeability
09/10/2010WO2010083439A3 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
09/10/2010WO2010083434A3 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
09/10/2010WO2010083347A3 Peptidomimetic macrocycles
09/10/2010WO2010083320A3 Methods and compositions for the inhibition of thrombus formation
09/10/2010WO2010078916A4 Immunocytokines for tumour therapy with chemotherapeutic agents
09/10/2010WO2010073009A3 Peptide inhibitors of aquaporin-4 and their use
09/10/2010WO2010064838A3 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
09/10/2010WO2010058427A3 Process for production and purification of polymyxin b sulfate
09/10/2010WO2010057188A3 Fast-acting, dietary supplement containing compositions and methods of producing the compositions
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 3163